Metabolic dysfunction–associated fatty liver disease (MAFLD) is the most common chronic liver condition with a bidirectional relation with multimetabolic disorders. By considering lifestyle interventions as the approved treatment strategy, several herbal products have been examined as conjugated therapy in the prevention/treatment of the disease. The annual herbaceous plant known as Salvia hispanica L. (chia) is an ancient grain trending in modern diets. Chia seeds are not only an excellent source of nutrients and bioactive compounds but also have shown effectiveness in the management of a number of metabolic disorders. However, studies on MAFLD are limited and mainly include animal models. Moreover, the exact molecular mechanisms by which chia influences MAFLD-related outcomes remain inadequately investigated. Hence, the aim of the present comprehensive review is to explore the effectiveness of chia supplementation in MAFLD by various forms (seeds, oil, and flour) with a view point on molecular pathways, metabolic regulation, and clinical outcomes.
{"title":"A Comprehensive Review on the Therapeutic Effects of Salvia hispanica L. (Chia) on Metabolic Dysfunction–Associated Fatty Liver Disease: Special Focus on Pathogenesis","authors":"Maryam Parimi, Sara Arefhosseini, Helda Tutunchi, Seyed Rafie Arefhosseini, Mehrangiz Ebrahimi-Mameghani","doi":"10.1155/ijcp/8660821","DOIUrl":"https://doi.org/10.1155/ijcp/8660821","url":null,"abstract":"<p>Metabolic dysfunction–associated fatty liver disease (MAFLD) is the most common chronic liver condition with a bidirectional relation with multimetabolic disorders. By considering lifestyle interventions as the approved treatment strategy, several herbal products have been examined as conjugated therapy in the prevention/treatment of the disease. The annual herbaceous plant known as <i>Salvia hispanica</i> L. (chia) is an ancient grain trending in modern diets. Chia seeds are not only an excellent source of nutrients and bioactive compounds but also have shown effectiveness in the management of a number of metabolic disorders. However, studies on MAFLD are limited and mainly include animal models. Moreover, the exact molecular mechanisms by which chia influences MAFLD-related outcomes remain inadequately investigated. Hence, the aim of the present comprehensive review is to explore the effectiveness of chia supplementation in MAFLD by various forms (seeds, oil, and flour) with a view point on molecular pathways, metabolic regulation, and clinical outcomes.</p>","PeriodicalId":13782,"journal":{"name":"International Journal of Clinical Practice","volume":"2025 1","pages":""},"PeriodicalIF":2.4,"publicationDate":"2025-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ijcp/8660821","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145366398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The present study is a retrospective analysis of the activities of a tertiary stroke center (SC) operating on the basis of Akzhan Clinic in Karaganda Region during the year 2024. The primary objective of this study was to examine the epidemiological features, the structure of stroke morbidity, and the efficacy of thrombolytic therapy (TLT) in patients with ischemic stroke (IS). The study included data from a total of 585 patients, out of which 437 had been hospitalized with acute cerebrovascular disorders, and 104 of these patients had received TLT for IS. The analysis revealed a high level of utilization of TLT (23.8%), which was significantly higher than the average regional and national figures, owing to the efficient organization of prehospital and in-hospital stages, availability of skilled personnel, and a state-of-the-art technical infrastructure. Additionally, mechanical thrombectomy (MT) was performed in 100 instances, further confirming the high level of adoption of advanced treatment modalities. The proportion of hemorrhagic transformations (7.69%) and mortality (6.7%) was comparable to or lower than international benchmarks. The results demonstrate the high effectiveness of the performance of the SC “Akzhan” and the need for the further expansion of similar facilities in order to improve the accessibility and quality of stroke treatment in Kazakhstan.
{"title":"Evaluation of Stroke Care Delivery: 12-Month Experience of a Tertiary Stroke Center in Central Asia","authors":"Marina Grigolashvili, Dmitriy Klyuyev, Dmitry Kasatkin, Sharbanu Battakova, Yelena Shayakhmetova, Mira Beisembayeva, Shynar Muratbekova, Alina Koshelyuk, Yessenbay Baituyak, Ivan Turkevich, Alexey Dey","doi":"10.1155/ijcp/8109173","DOIUrl":"https://doi.org/10.1155/ijcp/8109173","url":null,"abstract":"<p>The present study is a retrospective analysis of the activities of a tertiary stroke center (SC) operating on the basis of Akzhan Clinic in Karaganda Region during the year 2024. The primary objective of this study was to examine the epidemiological features, the structure of stroke morbidity, and the efficacy of thrombolytic therapy (TLT) in patients with ischemic stroke (IS). The study included data from a total of 585 patients, out of which 437 had been hospitalized with acute cerebrovascular disorders, and 104 of these patients had received TLT for IS. The analysis revealed a high level of utilization of TLT (23.8%), which was significantly higher than the average regional and national figures, owing to the efficient organization of prehospital and in-hospital stages, availability of skilled personnel, and a state-of-the-art technical infrastructure. Additionally, mechanical thrombectomy (MT) was performed in 100 instances, further confirming the high level of adoption of advanced treatment modalities. The proportion of hemorrhagic transformations (7.69%) and mortality (6.7%) was comparable to or lower than international benchmarks. The results demonstrate the high effectiveness of the performance of the SC “Akzhan” and the need for the further expansion of similar facilities in order to improve the accessibility and quality of stroke treatment in Kazakhstan.</p>","PeriodicalId":13782,"journal":{"name":"International Journal of Clinical Practice","volume":"2025 1","pages":""},"PeriodicalIF":2.4,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ijcp/8109173","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145317609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}